CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes-Reference-Cited by-同舟云学术

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes

Published:2014-03 Issue:1-2 Volume:158 Page:134-142
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Camperio Cristina,Muscolini Michela,Volpe Elisabetta,Di Mitri Diletta,Mechelli Rosella,Buscarinu Maria C.,Ruggieri Serena,Piccolella Enza,Salvetti Marco,Gasperini Claudio,Battistini Luca,Tuosto Loretta

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis;Bielekova;J Immunol,2004

2. Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases;Bielekova;J Immunol,2000

3. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm;Batoulis;Ann Anat,2010

4. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells;Stromnes;Nat Med,2008

5. Multiple sclerosis—the plaque and its pathogenesis;Frohman;N Engl J Med,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing CD28 attenuated chest blast exposure-induced traumatic brain injury through the PI3K/AKT/NF-κB signaling pathway in male mice;Brain Research Bulletin;2024-08

2. Natural isoaspartyl protein modification of ZAP70 alters T cell responses in lupus;Autoimmunity;2023-11-23

3. Human IL-17A protein production is controlled through a PIP5K1α-dependent translational checkpoint;Science Signaling;2023-10-24

4. Bivalent binding of staphylococcal superantigens to the TCR and CD28 triggers inflammatory signals independently of antigen presenting cells;Frontiers in Immunology;2023-05-03

5. Beyond PI3Ks: targeting phosphoinositide kinases in disease;Nature Reviews Drug Discovery;2022-11-14